XML 59 R45.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ / shares in Units, ₪ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2021
USD ($)
Dec. 18, 2020
USD ($)
Apr. 28, 2019
USD ($)
May 25, 2018
USD ($)
shares
Jan. 04, 2018
USD ($)
$ / shares
Jan. 04, 2018
ILS (₪)
Jun. 30, 2012
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 10, 2021
USD ($)
$ / shares
Dec. 31, 2020
$ / shares
Loss Contingencies [Line Items]                    
Monthly consultation fee | ₪           ₪ 40,000        
Monthly consultation fee in USD | $ / shares         $ 12.86          
Currency exchange rate, description         exchange rate of NIS 3.11 to the dollar exchange rate of NIS 3.11 to the dollar        
Common stock par value | $ / shares               $ 0.01   $ 0.01
Litigation settlement   $ 485                
Joseph Mona [Member]                    
Loss Contingencies [Line Items]                    
Purchase price of plaintiffs $ 484                  
Securities Purchase Agreement [Member]                    
Loss Contingencies [Line Items]                    
Settlement amount               $ 3,700    
Number of post-stock split shares returned | shares               83,333    
Purchase price of plaintiffs               $ 6,750    
CardioSert Ltd [Member]                    
Loss Contingencies [Line Items]                    
Initial payment       $ 250 $ 50          
Number of common shares acquired | shares       6,738            
Number of common shares acquired, value       $ 74            
Buy back amount per patent | $ / shares         $ 1.00          
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                    
Loss Contingencies [Line Items]                    
Common stock par value | $ / shares                 $ 0.01  
Offering costs                 $ 10,000  
Alliance Investment Management, Ltd. [Member]                    
Loss Contingencies [Line Items]                    
Litigation settlement     $ 468              
Minimum [Member] | CardioSert Ltd [Member]                    
Loss Contingencies [Line Items]                    
Investments         $ 2,000          
Minimum [Member] | Technion Research and Development Foundation Limited [Member]                    
Loss Contingencies [Line Items]                    
Royalties payable as percentage of future sales             1.50%      
Maximum [Member] | Technion Research and Development Foundation Limited [Member]                    
Loss Contingencies [Line Items]                    
Royalties payable as percentage of future sales             3.00%      
2013 Through December 31, 2020 [Member] | Israeli Innovation Authority [Member]                    
Loss Contingencies [Line Items]                    
Total grants obtained               $ 1,500    
2013 Through December 31, 2020 [Member] | Israeli Innovation Authority [Member] | Minimum [Member]                    
Loss Contingencies [Line Items]                    
Royalties payable as percentage of future sales               3.00%    
2013 Through December 31, 2020 [Member] | Israeli Innovation Authority [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Royalties payable as percentage of future sales               3.50%